SCRS Talks
Podcast tekijän mukaan Society for Clinical Research Sites - Maanantaisin
Kategoriat:
159 Jaksot
-
AI in Action: Transforming Patient Recruitment in Clinical Trials
Julkaistiin: 26.12.2023 -
Innovating Patient Recruitment: Winning Approaches
Julkaistiin: 19.12.2023 -
Breaking Barriers in Cancer Research & Care
Julkaistiin: 6.12.2023 -
Site-Centric Strategies: Merck's Approach to Collaboration
Julkaistiin: 28.11.2023 -
Meet Global Impact Partner: Tekton Research
Julkaistiin: 8.11.2023 -
Navigating Site Budgets with Inflation & The Great Resignation
Julkaistiin: 1.11.2023 -
The Unseen Side of Clinical Trials
Julkaistiin: 25.10.2023 -
Inside the World of Clinical Research Project Management with ACRPM
Julkaistiin: 17.10.2023 -
Behind the Scenes of SCRS' European Summit: What to Expect
Julkaistiin: 9.10.2023 -
Partnerships & Impact: How Greater Gift Celebrates Clinical Trial Heroes
Julkaistiin: 2.10.2023 -
Meet New Global Impact Partner: Accelerated Enrollment Solutions
Julkaistiin: 25.9.2023 -
Sites of the Future: How to Be Technology-Forward
Julkaistiin: 18.9.2023 -
Mastering Clinical Research Workforce Challenges
Julkaistiin: 11.9.2023 -
Understanding the True Cost of Clinical Technology
Julkaistiin: 4.9.2023 -
Global Summit Preview: Ignite the Possibilities
Julkaistiin: 28.8.2023 -
Empowering Diversity: Meet Latinos in Clinical Research
Julkaistiin: 21.8.2023 -
Tech Transformation: Overcoming Challenges with Site-Level Integration
Julkaistiin: 14.8.2023 -
Collaboration for Health Equity: How Health Data For Good Leads the Way
Julkaistiin: 7.8.2023 -
Meet SCRS Global Impact Partner: YPrime
Julkaistiin: 2.8.2023 -
EHR Data into EDC: Making it Simpler for Sites
Julkaistiin: 25.7.2023
SCRS Talks, hosted by the Society for Clinical Research Sites (SCRS), is a platform for clinical research industry professionals to hear about valuable information shaping the research industry today. These short interviews will provide new perspectives and insights on pressing topics, current events, and the research community.